Rocket Lab's 31.5%-Efficient IMM Cell and Idemitsu's CIGS Lab Signal a Space Solar Cell Shakeup

The space solar cell market has spent decades anchored to a single substrate — germanium — and a single architecture: triple-junction III-V. Two announcements in September 2026 suggest that anchor is lifting. Rocket Lab's new inverted metamorphic multijunction (IMM) Apex cell, released on 11 September 2026, achieves 31.5% beginning-of-life conversion efficiency without a germanium wafer, while Japanese oil refiner Idemitsu opened a South Carolina development laboratory for space-grade copper indium gallium-selenide (CIGS) solar cells — a thin-film architecture that has never held meaningful market share in space — on 10 September 2026. Together, the moves represent the most concentrated pressure on legacy space-cell suppliers in years, and they matter to anyone specifying power systems for satellites, lunar surface assets, or future space-based solar power (SBSP) demonstrations.

What does Rocket Lab's IMM Apex cell actually prove — and what does it not yet prove?

Rocket Lab's inverted metamorphic multijunction (IMM) cell is fabricated by growing the semiconductor layers in reverse order on a temporary substrate, then releasing them — a process that enables higher-bandgap top junctions and eliminates the need for a germanium base wafer. Germanium is both expensive and classified as a critical mineral with concentrated supply chains, so its removal addresses two programme-office concerns simultaneously. The Rocket Lab IMM Apex cell (2026-09-11) is reported as 40% lighter than legacy triple-junction products and is designed as a drop-in replacement for existing panel architectures, meaning spacecraft integrators do not need to redesign their array structures to adopt it.

At 31.5% beginning-of-life (BOL) efficiency as of September 2026, the Apex cell is competitive with the upper range of production triple-junction germanium cells, which typically land between 28% and 32% BOL depending on the supplier and the measurement standard. What the Rocket Lab announcement does not yet tell us is end-of-life (EOL) efficiency after radiation fluence — the number that actually governs satellite power budgets over a 15-year mission. Specific power (watts per kilogram, W/kg) for a finished panel assembly, not just the bare cell, is also not yet publicly quoted. Engineers should treat this as a strong laboratory-to-commercial milestone: it proves the architecture works at production scale and removes a supply-chain single point of failure, but it is not yet an orbital demo with EOL data.

For spacecraft and orbital-infrastructure programmes, the 40% mass reduction claim is the figure worth stress-testing. Panel mass is a direct input to launch cost, which at current commercial rideshare pricing still runs in the thousands of dollars per kilogram to low Earth orbit (LEO). A lighter array compounds across the entire spacecraft mass budget.

Is CIGS a credible competitor for space applications, and why is Idemitsu moving now?

CIGS — copper indium gallium-selenide — is a polycrystalline thin-film material well-established in terrestrial utility solar, where it competes on cost-per-watt rather than efficiency. In space, the calculus is different: radiation tolerance, specific power, and flexibility matter more than raw efficiency. CIGS has demonstrated notable radiation hardness in research settings, which is why interest in space-grade variants has persisted despite the technology's absence from operational satellite fleets.

Idemitsu's South Carolina laboratory (2026-09-10) is conducting prototype-level work toward commercialisation of space-grade CIGS cells. The choice of a U.S. facility is strategically legible: American defence and civil space procurement programmes increasingly require domestic or allied supply chains, and a South Carolina lab positions Idemitsu inside that perimeter. Idemitsu's background as an oil refiner gives it materials-processing depth, but the company has not yet published efficiency or specific-power targets for its space-grade CIGS prototypes. This is firmly pre-commercial — a technology readiness level (TRL) 3–4 activity at best — and should be read as a market-entry signal, not a near-term procurement option.

What this means for your next specification decision

The simultaneous appearance of a commercialised IMM product and an early-stage CIGS programme tells a consistent story: the germanium-dependent triple-junction monopoly is under real competitive pressure for the first time in a generation. For programme managers specifying arrays for satellites launching in 2027–2029, the Rocket Lab IMM Apex cell is the actionable item — request radiation-hardness and EOL-efficiency data sheets now, and compare specific power at the panel level, not just the cell level, before committing. For those with longer planning horizons — lunar surface power systems, SBSP technology demonstrators, or deep-space probes — Idemitsu's CIGS work is worth monitoring as a potential second-source path, particularly if radiation-tolerance data from the South Carolina lab supports the theoretical advantage. The supply-chain diversification argument alone justifies keeping both on your technology watch list.